Institutional Biosafety Committee Review for Genetically Modified Vaccines and Gene Transfer Products

October 13, 2020
Previous Video
90 Second Insights: Assessing the Realities of Site Crunch: Outfitting your sites with the support they need
90 Second Insights: Assessing the Realities of Site Crunch: Outfitting your sites with the support they need

Next Video
90 Second Insights: Assessing the Realities of "Site Crunch": Decreasing PI participation vs. Increasing trial start-ups
90 Second Insights: Assessing the Realities of "Site Crunch": Decreasing PI participation vs. Increasing trial start-ups